Andrew Murphy - Mar 13, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research
Signature
/s/**Andrew Murphy
Stock symbol
REGN
Transactions as of
Mar 13, 2024
Transactions value $
-$11,354,454
Form type
4
Date filed
3/15/2024, 04:01 PM
Previous filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock +Options Exercise $7,993,200 +20,000 +41.4% $399.66 68,306 Mar 13, 2024 Direct F1
transaction REGN Common Stock -Tax liability -$13,816,365 -14,217 -20.81% $971.82 54,089 Mar 13, 2024 Direct F1
transaction REGN Common Stock -Sell -$173,249 -182 -0.34% $951.92 53,907 Mar 14, 2024 Direct F1, F2
transaction REGN Common Stock -Sell -$422,866 -444 -0.82% $952.40 53,463 Mar 14, 2024 Direct F1, F3
transaction REGN Common Stock -Sell -$549,372 -576 -1.08% $953.77 52,887 Mar 14, 2024 Direct F1, F4
transaction REGN Common Stock -Sell -$830,554 -870 -1.65% $954.66 52,017 Mar 14, 2024 Direct F1, F5
transaction REGN Common Stock -Sell -$520,769 -545 -1.05% $955.54 51,472 Mar 14, 2024 Direct F1, F6
transaction REGN Common Stock -Sell -$1,059,625 -1,108 -2.15% $956.34 50,364 Mar 14, 2024 Direct F1, F7
transaction REGN Common Stock -Sell -$698,866 -730 -1.45% $957.35 49,634 Mar 14, 2024 Direct F1, F8
transaction REGN Common Stock -Sell -$457,128 -477 -0.96% $958.34 49,157 Mar 14, 2024 Direct F1, F9
transaction REGN Common Stock -Sell -$491,192 -512 -1.04% $959.36 48,645 Mar 14, 2024 Direct F1, F10
transaction REGN Common Stock -Sell -$45,202 -47 -0.1% $961.74 48,598 Mar 14, 2024 Direct F1
transaction REGN Common Stock -Sell -$963 -1 0% $962.87 48,597 Mar 14, 2024 Direct F1
transaction REGN Common Stock -Sell -$75,310 -78 -0.16% $965.51 48,519 Mar 14, 2024 Direct F1, F11
transaction REGN Common Stock -Sell -$16,427 -17 -0.04% $966.30 48,502 Mar 14, 2024 Direct F1
transaction REGN Common Stock -Sell -$189,767 -196 -0.4% $968.20 48,306 Mar 14, 2024 Direct F1, F12
holding REGN Common Stock 4,310 Mar 13, 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) -Options Exercise $0 -20,000 -50% $0.00 20,000 Mar 13, 2024 Common Stock 20,000 $399.66 Direct F1, F13

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
F2 Represents volume-weighted average price of sales of 182 shares of Company stock on March 14, 2024 at prices ranging from $951.89 to $951.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 444 shares of Company stock on March 14, 2024 at prices ranging from $952.00 to $952.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 576 shares of Company stock on March 14, 2024 at prices ranging from $953.30 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 870 shares of Company stock on March 14, 2024 at prices ranging from $954.01 to $954.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 545 shares of Company stock on March 14, 2024 at prices ranging from $955.02 to $955.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F7 Represents volume-weighted average price of sales of 1,108 shares of Company stock on March 14, 2024 at prices ranging from $956.08 to $956.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F8 Represents volume-weighted average price of sales of 730 shares of Company stock on March 14, 2024 at prices ranging from $957.02 to $957.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F9 Represents volume-weighted average price of sales of 477 shares of Company stock on March 14, 2024 at prices ranging from $958.06 to $958.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F10 Represents volume-weighted average price of sales of 512 shares of Company stock on March 14, 2024 at prices ranging from $959.13 to $959.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F11 Represents volume-weighted average price of sales of 78 shares of Company stock on March 14, 2024 at prices ranging from $965.26 to $965.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F12 Represents volume-weighted average price of sales of 196 shares of Company stock on March 14, 2024 at prices ranging from $968.15 to $968.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
F13 The stock option award vests in four equal annual installments, commencing one year after the date of grant.